CENBF (CEN Biotech) Market Cap: $0.00 Mil (As of Jun. 30, 2026)


What is CEN Biotech Market Cap?

CEN Biotech CENBF Market Cap is $0.00 Mil as of Jun. 30, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CEN Biotech's share price for the quarter that ended in Mar. 2023 was $0.02. CEN Biotech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2023 was 65.26 Mil. Therefore, CEN Biotech's market cap for the quarter that ended in Mar. 2023 was $1.31 Mil.

CEN Biotech's quarterly market cap declined from Sep. 2022 ($5.76 Mil) to Dec. 2022 ($2.66 Mil) and declined from Dec. 2022 ($2.66 Mil) to Mar. 2023 ($1.31 Mil).

CEN Biotech's annual market cap declined from Dec. 2020 ($56.49 Mil) to Dec. 2021 ($11.75 Mil) and declined from Dec. 2021 ($11.75 Mil) to Dec. 2022 ($2.66 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CEN Biotech's Enterprise Value for Today is $0.00 Mil.

CEN Biotech  (OTCPK:CENBF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

CEN Biotech Market Cap Related Terms

CEN Biotech Market Cap Historical Data

* Premium members only.

The historical data trend for CEN Biotech's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CEN Biotech Market Cap Chart

CEN Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
Get a 7-Day Free Trial Premium Member Only 52.22 55.25 56.49 11.75 2.66

CEN Biotech Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.18 4.33 5.76 2.66 1.31

CENBF vs INLB, NEPT, SGBI: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CEN Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CEN Biotech Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CEN Biotech's Market Cap distribution charts can be found below:

* The bar in red indicates where CEN Biotech's Market Cap falls into.


CEN Biotech Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

CEN Biotech's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=$0.0411*64.741
=$2.66

CEN Biotech's Market Cap for the quarter that ended in Mar. 2023 is calculated as

Market Cap (Q: Mar. 2023 )=Share Price (Q: Mar. 2023 )*Shares Outstanding (EOP) (Q: Mar. 2023 )
=$0.02*65.256
=$1.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.00 Mil mean?
CEN Biotech (CENBF) has a Market Cap of $0.00 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CEN Biotech and its competitors.
Is CEN Biotech's Market Cap too high?
CEN Biotech's current Market Cap is $0.00 Mil.
How does CEN Biotech's Market Cap compare to INLB and NEPT?
CEN Biotech's Market Cap of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 206.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.61, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CEN Biotech and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CEN Biotech's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CEN Biotech stock overvalued right now?
CEN Biotech (CENBF) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For CEN Biotech (CENBF), the current Market Cap is $0.00 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CEN Biotech Business Description

Address 3295 Quality Way, Suite 300, Windsor, ON, CAN, N8T 3R9
CEN Biotech Inc is an early-stage Canadian biopharmaceutical company. The Company grows, sells, and delivers pharmaceutical-grade medical marijuana to patients.